2024 Plastic surgery statistics
University of Tokyo Press
During 72 weeks of treatment, people taking tirzepatide at doses of 5, 10, or 15 mg lost an average of 15.0%, 19.5%, and 20.9%, respectively, compared with just 3.1% in people taking placebo
Two design quirks, however, could make it cost more than it appears
However, some patients switch from brand-name pens to compounded vials for cost reasons
A Holistic Viewpoint GLP-1 medications intersect with surgical care across three domains: surgical timing and technique, metabolic and glycemic control, and pharmacologic effects that influence perioperative risk